Dare Bioscience acquires Cerulean in reverse merger
Public biotech Cerulean Pharma Inc. (nanoparticle drug delivery) is reverse-merging with private women's health start-up Dare Bioscience Inc. to create a female reproductive health-focused company.
- Drug Delivery
- Includes Contract
- Payment Includes Stock
- Reverse Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com